medigraphic.com
ISSN 2078-7162 (Print)

2020, Number 3

<< Back Next >>

Rev Cub de Med Fis y Rehab 2020; 12 (3)

Comprehensive rehabilitation protocol for patients post-infection with SARS-CoV-2 virus from COVID-19

Piedra JS, Rodríguez HEI, Cuellar CT, García LAL

Language: Spanish
References: 51
Page:
PDF size: 543.68 Kb.


ABSTRACT

The COVID-19 pandemic is affecting 185 countries. Cuba is not unaware of this reality, despite the epidemiological control achieved. The high virulence and 4.1% lethality of this new CoV-2 cause many patients to die. In others, it leaves sequels according to its respiratory, cardiovascular, neurological, renal, nutritional, immunological and osteomioarticular complications. The aim of the article is to develop a comprehensive rehabilitative treatment protocol for post-infection SARS-CoV-2 to COVID-19 patients at the International Health Center “La Pradera”. For this purpose, international databases, expert opinions and good practice guidelines were reviewed. As it is a new entity, no unified information on the subject is collected. Therefore, it must be kept in constant research. The multisystemic affectation of SARS-CoV-2 virus can express serious forms of the disease related to risk factors. Patients, even after hospital admission, maintain symptoms ranging from difficulty breathing, coughing, fatigue, muscle weakness, and limitations in daily activities, to emotional and cognitive disorders associated with complications. Comprehensive rehabilitation is continuous, imposing treatment guidelines to restore the patient's physical, psychological and social condition. It is concluded that the application of the protocol or rehabilitation guide in “La Pradera” provides a specialized, competitive, safe and personalized multidisciplinary medical assistance for patients with COVID-19 post-infection. Results are guaranteed with scientific basis of medicine, international recognition and humane treatment taking into account the cost-quality relationship to achieve social reintegration and quality of life.


REFERENCES

  1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020; 92:401-2. DOI: http://10.1002/jmv.256782

  2. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020; 395:470-3. DOI: http://10.1016/S0140-6736(20)30185-93

  3. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; e201127. DOI: http://10.1001/jamaneurol.202 0.11274

  4. Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. 2020; 92(7):833-40. DOI: http://10.1002/jmv.25825

  5. Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020; 92:552-5. DOI: http://10.1002/jmv.25728

  6. Brookes NRG, Fairley MW, Brookes GB. Acute Olfactory Dysfunction-A Primary Presentation of COVID-19 Infection; 1-5. DOI: http://10.1177/0145561320940119

  7. Klopfenstein T, Kadiane-Oussou NJ, Toko L, Royera PY, Lepillerb Q, Gendrin V, et al. Features of anosmia in COVID-19. Med Mal Infect. 2020. 50(5):436-9. DOI: http://doi:10.1016/j.medmal.2020.04.006

  8. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020. 395:565-74. DOI: http://10.1016/S0140-6736(20)30251

  9. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382:1708-20. DOI: http://10.1056/NEJMoa2002032

  10. Arbesú AL. Covid-19: positiva estrategia/COVID-19: A Positive Strategy. Rev Cuba Internacional 2020 [acceso: 02/06/2020]; 463:15. Disponible en: https://www.prensa-latina.cu/images/2020/Publicaciones/CubaInternacional/Cuba463.pdf

  11. Puig Meneses Y. Protocolos cubanos para tratar la COVID-19, vitales en la evolución clínica de los pacientes [acceso: 10/07/2020]. Disponible en http://www.granma.cu/cuba-covid-19/2020-07-10/protocolos-cubanos-para-tratar-la-covid-19-vitales-en-la-evolucion-clinica-de-los-pacientes-10-07-2020-00-07-01

  12. Milanés L. Covid-19: Protocolo y bioseguridad en Cuba (+ Infografías). 2020; [acceso: 02/06/2020]. Disponible en: https://www.cubahora.cu/ciencia-y-tecnologia/covid-19-protocolo-y-bioseguridad-en-cuba

  13. Protocolo Nacional MINSAP vs. COVID-19. [acceso: 20/05/2020]. Disponible en: http://www.sld.cu/anuncio/2020/05/11/ministerio-de-salud-publica-protocolo-de-actuacion-nacional-para-la-covid19

  14. Tan W, Zhao X, Ma X. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19)-China, 2020 China CDC Weekly 2020 [acceso: 22/06/20]; 2(8):113-22. Disponible en: http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51

  15. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 New England. Journal of Medicine. 2020; 382:727-33. DOI: http://10.1056/NEJMoa2001017

  16. Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020. DOI: http://10.1002/jmv.25915

  17. Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol. 2020; 35:744-8. DOI: http://10.1111/jgh.15047

  18. Wan S, Yi Q, Fan S, Lu J, Zhang X, Guo L, et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). medRxiv. 2020; 1-7. DOI: https://doi.org/10.1101/2020.02.10.20021832

  19. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020; 94:809-10. DOI: http://10.1212/WNL.0000000000009455

  20. Swanson PA 2nd, McGavern DB. Viral diseases of the central nervous system. Curr Opin Virol. 2015; 11:44-54. DOI: http://10.1016/j.coviro.2014.12.009

  21. Avula A, Nalleballe K, Narula N, Sapozhnikovc S, Dandub V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020; 87:115-9. DOI: http://10.1016/j.bbi.2020.04.077

  22. Al Saiegh F, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. J Neurol Neurosurg Psychiatry. 2020; 91(8):846-8. DOI: http://10.1136/jnnp-2020-3 23522

  23. Oxley TJ, Mocco J, Majidi S, Kellner CP, Shoirah H, Singh IP, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020; 382:e60. DOI: http://10.1056/NEJMc20 09787

  24. Moriguchi T, Harii N, Goto J, Haradaa D, Sugawaraa H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-CoV-2. Int J Infect Dis. 2020; 94:55-58. DOI: http://10.1016/j.ijid.2020.03.062

  25. Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020; 19:383-4. DOI: http://10.1016/S1474-4422

  26. Serra-Valdés M. Las enfermedades crónicas no transmisibles y la pandemia por COVID-19. Revista Finlay. 2020; 10(2). Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/846/1870

  27. OPS/OMS. Agenda de Salud Sostenible para las Américas 2018-2030. Objetivo 9: Enfermedades no transmisibles. Ginebra: OMS. 2020 [acceso: 25/06/2020]. Disponible en: https://www.paho.org/es/agenda-salud-sostenible-para-americas-2018-2030/agenda-salud-sostenible-para-americas-2018-2030-6

  28. Klok FA, Kruip MJHA, van der Meer NJM, Arbousd MS, Gommerse DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191:145-7. DOI: http://10.1016/j.thromres.2020.04.013

  29. Belluck P. Así es la recuperación para muchos de los sobrevivientes de la COVID-19. The New York Times. 2020. Disponible en: https://www.nytimes.com/es/2020/07/02/espanol/ciencia-tecnologia/sobrevivientes-coronavirus-recuperacion.html

  30. Jiang X, Chen J, Cen F, Li X, Song Z, Peng M, et al. Importance of respiratory airway management as well as psychological and rehabilitative treatments to COVID-19 patiens. American Journal of Emergency Medicine 2020; 38(8):1698.e1-1698.e4. DOI: https://doi.org/10.1016/j.ajem.2020.04.055

  31. Feng W, Zong W, Wang F. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review Mol Cancer. 2020; 19(100). DOI: https://doi.org/10.1186/s12943-020-01218-1

  32. Andrenelli E, Negrini F, De Sire A, Arienti CH, Patrini M, Negrini S, et al. Systematic rapid living review on rehabilitation needs due to Covid-19: update to May 31st 2020. European Journal of Physical and Rehabilitation Medicine 2020; 56(3):347-53. DOI: https://10.23736/S1973-9087.20.06435-7

  33. Pan SF, Zhang HY, Li CS, Wang C, Zhonghua J, He H, et al. Cardiac arrest in severe acute respiratory syndrome: analysis of 15 cases. 2003; 26(10):602-5. Disponible en: https://pubmed.ncbi.nlm.nih.gov/14633442/

  34. Zhou F, Yu T, Du R, Fan G, Lui Y. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1-20. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3

  35. Kalantar-Zadeh K, Moore LW. Impact of Nutrition and Diet on COVID-19. Infection and Implications for Kidney Health and Kidney Disease Management. Journal of Renal Nutrition. May 2020; 30(3):179-81. DOI: https://10.1053/j.jrn.2020.03.006

  36. Trilla A. Respuesta inmunitaria contra el coronavirus. Madrid: La Vanguardia [acceso: 16/06/2020]. Disponible en: https://www.lavanguardia.com/vida/20200304/473962317182/coronavirus-respuesta-inmunitaria-experto-organismo-claves.html

  37. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. bioRxiv [preprint]. 2020; 1-13. DOI: https://10.1101/2020.01.26.919985

  38. Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. 2004; 25:291-4. DOI: https://10.1016/j.tips.2004.04.001

  39. Chen C, Zhang XR, Ju ZY, He WF. [Advances in the research of cytokine storm mechanism induced by Corona Virus Disease 2019 and the corresponding immunotherapies]. Zhonghua Shao Shang Za Zhi. 2020; 36:E005. DOI: https://10.3760/cma.j.cn501120-20200224-00088

  40. Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, Karim AH and Sattar A Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review. Front. Neurol. 2020; 11:518. DOI: https://10.3389/fneur.2020.00518

  41. Letter to the editor. Rehabilitation of COVID-19 patients. J Rehabil Med 2020; 52:jrm00046 Journal Compilation. DOI: https://10.2340/16501977-2678

  42. Carda S. The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician’s view. Ann Phys Rehabil Med 2020. DOI: https://doi.org/10.1016/j.rehab.2020.04.001

  43. Lu L, Yang T. Pulmonary Rehabilitaction for patients with coronavirus disease 2019(COVID-19). Review. Chronic disease and translational medicine 6 2020; 79-86. DOI: https://doi.org/10.1016/j.cdtm.2020.05.002 2095-882

  44. Prvu Bettger J, Thoumi A, Marquevich V, De Groote W, Rizzo Battistella L, Imamura M, et al. COVID-19: maintaining essential rehabilitation services across the care continuum BMJ Global Health 2020; 5:e002670. DOI: https://10.1136/bmjgh-2020-002670

  45. Sheehy LM. Considerations for Postacute Rehabilitation for Survivors of COVID-19. JMIR Public Health Surveill. Apr-Jun 2020; 6(2):e19462. DOI: https://10.2196/19462

  46. Maestú Puente L, García de Pedro J. Pruebas de función respiratoria y broncoscopia, Hospital General Gregorio Marañón, Universidad Complutense de Madrid, Madrid. Las pruebas funcionales respiratorias en las decisiones clínicas. Arch Bronconeumol. 2012; 48(5):161-9. DOI: https://10.1016/j.arbres.2011.12.012

  47. Mottram Carl. Spirometry interpretation. Mottram CD. Manual of Pulmonary Function Testing. Mayo Clinic College of Medicine, 2012 [acceso: 25/06/2020]; Chapter 6. Disponible en: https://www.elsevier.com/books/ruppels-manual-of-pulmonary-function-testing/mottram/978-0-323-08505-2

  48. Rivas-Estany E, Barrera Sandey JD, Sixto-Fernández S, Rodríguez Nande LM, Kesser-García C. Programa cubano de rehabilitación cardíaca. Resultados. Rehabilitación (Madr). 2013 [acceso: 25/06/2020]. DOI: http://dx.doi.org/10.1016/j.rh.2013.07.003

  49. Giuseppe Sergi, De Rui M, Stubbs B, Veronese N, Manzato E. Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons. Aging Clinical and Experimental Research. 2017; 29:591-7.

  50. Haro M. Laboratorio de análisis de marcha y movimiento D. Rev. Med. Clin. Conde. 2014; 25(2)237-47.

  51. Bikson M, Hanlon CA, Woods AJ, Gillick BT, Charvet L, Lamm C, Madeo G, et al. Guidelines for TMS/tDES clinical services and research through the COVID-19 pandemic. Brain Stimulation July-August. 2020. 13(4):1124-49. DOI: https://doi.org/10.1016/j.brs.2020.05.010.




2020     |     www.medigraphic.com